机构地区:[1]武汉大学中南医院检验科,430071 [2]武汉大学中南医院感染科,430071 [3]武汉市皮肤病防治研究所
出 处:《中华传染病杂志》2018年第12期736-740,共5页Chinese Journal of Infectious Diseases
基 金:湖北省自然基金面上项目(2015CFB665).
摘 要:目的探讨联合抗反转录病毒治疗(combined antiretroviral therapy,cART)与HIV阳性MSM者肛门人乳头状瘤病毒(human papillomavirus,HPV)感染的关系。方法选择2012年6月至2013年12月武汉市皮肤病防治所就诊的MSM者为研究对象,HIV阳性81例,阴性50例。比较HIV阳性和阴性MSM者的HPV感染状况,以及cART前后HIV阳性MSM者肛门HPV感染率和尖锐湿疣的发病率。HPV分型采用通用引物PCR和反向点杂交技术建立的检测方法。统计学分析采用t检验和χ2检验。结果HIV阳性MSM者任何型、高危型和多重HPV感染率高于HIV阴性的MSM者,分别为91.4%比62.0%、75.3%比30.0%和56.8%比20.0%(χ2值分别为16.75、26.05和19.10,均P<0.05)。cART持续36个月与cART前比较,77例HIV阳性MSM者肛门任何型、高危型和多重HPV感染率显著降低,分别为90.9%比74.0%、75.3比44.2%和57.1%比41.5%(χ2值分别为7.590、15.551和3.741,均P<0.05)。HPV16型和43型感染率由cART前的27.3%降至15.6%和13.0%(χ2值分别为16.92和14.86,均P<0.05),尖锐湿疣的发病率由16.9%降至5.2%(χ2=4.069,P<0.05)。结论HIV阳性MSM者肛门HPV感染率高于HIV阴性MSM者,cART可降低肛门HPV感染率和尖锐湿疣的发病率,尤其是降低高危型HPV感染率。Objective To investigate the effect of combined antiretroviral therapy (cART) on anal human papillomavirus (HPV) infection in human immunodeficiency virus (HIV)-infected men who sex with men (MSM). Methods HIV-infected MSM na?ve of cART who visited Wuhan Dermatological Hospital from June 2012 to December 2013 were enrolled in a longitudinal study before starting cART, including 81 HIV-positive and 50 HIV-negative cases.HPV infection situations between HIV-positive and HIV-negative MSM were compared.And anal HPV infection rate and condyloma acuminate incidence of HIV-positive MSM before and after cART were also compared.HPV genotyping was performed by universal primer PCR and reverse dot hybridization.The statistical analysis was done by t test or χ2 test. Results The prevalence rates of HPV infection, high-risk HPV infection and multiple HPV subtypes infection in HIV-positive MSM were all significantly higher than those in HIV-negative MSM (91.4% vs 62.0%, 75.3% vs 30.0%, 56.8% vs 20.0%, respectively, χ2=16.75, 26.05, and 19.10, respectively, all P<0.05).The prevalence rates of anal HPV infection, high-risk HPV infection and multiple HPV subtypes infection in 77 HIV-positive MSM at month 36 of cART were all significantly decreased than baseline (90.9% vs 74.0%, 75.3% vs 44.2% and 57.1% vs 41.5%, respectively, χ2=7.590, 15.551, and 3.741, respectively, all P<0.05).HPV16 and HPV43 infection rates were reduced from 27.3% at baseline to 15.6% and 13.0%, respectively at month 36 of cART (χ2=16.92 and 14.86, respectively, both P<0.05).Condyloma acuminate incidence also reduced from 16.9% at baseline to 5.2% at month 36 (χ2=4.069, P<0.05). Conclusions The prevalence of anal HPV infection in HIV-positive MSM is higher than HIV-negative MSM.cART could reduce the prevalence of anal HPV infection rate and condyloma acuminate incidence , especially high-risk HPV infection.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...